Ganoderma lucidum: Novel Insight into Hepatoprotective Potential with Mechanisms of Action
- PMID: 37111092
- PMCID: PMC10146730
- DOI: 10.3390/nu15081874
Ganoderma lucidum: Novel Insight into Hepatoprotective Potential with Mechanisms of Action
Abstract
Ganoderma lucidum (G. lucidum) has been widely used for its health benefits as an edible and traditional medicinal mushroom for thousands of years in Asian countries. It is currently used as a nutraceutical and functional food owing to its major bioactive compounds, polysaccharides and triterpenoids. G. lucidum exhibits a broad range of hepatoprotective impacts in various liver disorders, such as hepatic cancer, nonalcoholic fatty liver disease (NAFLD), alcohol-induced liver disease, hepatitis B, hepatic fibrosis, and liver injury induced by carbon tetrachloride (CCl4) and α-amanitin. G. lucidum protects the liver through a broad range of mechanisms that include the modulation of liver Phase I and II enzymes, the suppression of β-glucuronidase, antifibrotic and antiviral actions, the regulation of the production of nitric oxide (NO), the maintenance of hepatocellular calcium homeostasis, immunomodulatory activity, and scavenging free radicals. G. lucidum could signify an encouraging approach for the management of various chronic hepatopathies, and its potential mechanisms make it a distinctive agent when used alone or with other drugs and applied as a functional food, nutraceutical supplement, or adjuvant to modern medicine. This review summarizes the hepatoprotective properties of G. lucidum with its various mechanisms of action on different liver ailments. Biologically active substances derived from G. lucidum are still being studied for their potential benefits in treating different liver ailments.
Keywords: NAFLD; alcohol; cancer; hepatoprotective; mechanisms; nutritional constituents.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
Hepatoprotective Effects and Mechanisms of Action of Triterpenoids from Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) on α-Amanitin-Induced Liver Injury in Mice.Int J Med Mushrooms. 2016;18(9):841-850. doi: 10.1615/IntJMedMushrooms.v18.i9.80. Int J Med Mushrooms. 2016. PMID: 27910775
-
Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Liver Injury.Adv Exp Med Biol. 2019;1182:217-242. doi: 10.1007/978-981-32-9421-9_9. Adv Exp Med Biol. 2019. PMID: 31777021 Review.
-
Ganoderma lucidum: A potential source to surmount viral infections through β-glucans immunomodulatory and triterpenoids antiviral properties.Int J Biol Macromol. 2021 Sep 30;187:769-779. doi: 10.1016/j.ijbiomac.2021.06.122. Epub 2021 Jun 29. Int J Biol Macromol. 2021. PMID: 34197853 Review.
-
Probing Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes): a bitter mushroom with amazing health benefits.Int J Med Mushrooms. 2013;15(2):127-43. doi: 10.1615/intjmedmushr.v15.i2.20. Int J Med Mushrooms. 2013. PMID: 23557365 Review.
-
Therapeutic potential and nutritional significance of Ganoderma lucidum - a comprehensive review from 2010 to 2022.Food Funct. 2023 Feb 21;14(4):1812-1838. doi: 10.1039/d2fo01683d. Food Funct. 2023. PMID: 36734035
Cited by
-
Bioactivities and industrial standardization status of Ganoderma lucidum: A comprehensive review.Heliyon. 2024 Aug 29;10(19):e36987. doi: 10.1016/j.heliyon.2024.e36987. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39435114 Free PMC article. Review.
-
Optimization of ultrasonic-assisted debittering of Ganoderma lucidum using response surface methodology, characterization, and evaluation of antioxidant activity.PeerJ. 2024 Oct 14;12:e17943. doi: 10.7717/peerj.17943. eCollection 2024. PeerJ. 2024. PMID: 39421421 Free PMC article.
-
Ganoderma lingzhi (Reishi Mushroom)-Induced Acute Liver Injury in the Setting of Alcohol Use: A Case Report and Review of the Literature.Cureus. 2023 Sep 25;15(9):e45953. doi: 10.7759/cureus.45953. eCollection 2023 Sep. Cureus. 2023. PMID: 37885515 Free PMC article.
-
Regulatory effect of Ganoderma lucidum and its active components on gut flora in diseases.Front Microbiol. 2024 Mar 18;15:1362479. doi: 10.3389/fmicb.2024.1362479. eCollection 2024. Front Microbiol. 2024. PMID: 38572237 Free PMC article. Review.
-
Research Progress on the Biological Activity of Ganoderic Acids in Ganoderma lucidum over the Last Five Years.Life (Basel). 2024 Oct 21;14(10):1339. doi: 10.3390/life14101339. Life (Basel). 2024. PMID: 39459639 Free PMC article. Review.
References
-
- Liu J., Chen G., Yang J., Sheng L., Tang X., Zhang X., Hua H. Deciphering the chemical composition of Ganoderma lucidum from different geographical origins by mass spectrometry molecular networking coupled with multivariate analysis. Biomed. Chromatogr. 2023;37:e5506. doi: 10.1002/bmc.5506. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical